Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

Clinical trial NCT05675436 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05675436
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Sickle Cell Anemia Sickle Cell Thalassemia Sickle Cell Pain Hbss Hbsc Sickle Beta Thalassemia Sickle Beta Zero Thalassemia Sickle Cell Syndrome Variant

Start date: 2024-05-09
Primary completion: 2027-10-27
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.